Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-003996

Chief Operations Officer sold 7,000 shares at $18.84 ($131,880)

  • Chief Operations Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2021-01-15 Option exercise +3,500 $12.15 $42,525 116,555 D
Newell Joe Chief Operations Officer 2021-01-15 Sale −7,000 $18.84 $131,880 109,555 D
Derivatives
Newell Joe Chief Operations Officer 2021-01-15 Option exercise · Employee Stock Option (Right to Buy) −3,146 46,041 D
Newell Joe Chief Operations Officer 2021-01-15 Option exercise · Employee Stock Option (Right to Buy) −354 13,459 D
Open-market sales · 7,000 sh · avg $18.84 · $131,880
Loading xslF345X03/doc4.xml…